Combining an EGFR directed tyrosine kinase inhibitor with autophagy-inducing drugs: A beneficial strategy to combat non-small cell lung cancer

A mammalian protein targeted by G1-arresting rapamycin–receptor complex

Eric J. Brown, Mark W. Albers, Tae Bum Shin et al. · Nature · 1994 · 2.1K citations

Life Sciences, Molecular Biology, Pharmacology +11

mTOR and cancer: many loops in one pathway

Alejo Efeyan, David M. Sabatini · Current Opinion in Cell Biology · 2009 · 419 citations

Medicine, Cancer Biology, Oncology +12

Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors

Elizabeth Buck, Alexandra Eyzaguirre, Eric Brown et al. · Molecular Cancer Therapeutics · 2006 · 234 citations

Life Sciences, Oncology, Pharmacology +17

The anticancer drug imatinib induces cellular autophagy

Alexa Ertmer, Verena Huber, Sabine Gilch et al. · Leukemia · 2007 · 221 citations

Life Sciences, Cell Biology, Oncology +10

Rapamycin-Sensitive Pathway Regulates Mitochondrial Membrane Potential, Autophagy, and Survival in Irradiated MCF-7 Cells

Shoshana Paglin, Na-Young Lee, Charles Nakar et al. · Cancer Research · 2005 · 217 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17